EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
104 hedge funds and large institutions have $54M invested in Eagle Pharmaceuticals, Inc. in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 42 increasing their positions, 25 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
67% less capital invested
Capital invested by funds: $163M → $54M (-$109M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
104
Holding in Top 10
–
Calls
$522K
Puts
$58K
Top Buyers
| 1 | +$2.25M | |
| 2 | +$1.29M | |
| 3 | +$1.1M | |
| 4 |
Two Sigma Advisers
New York
|
+$1.04M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$953K |
Top Sellers
| 1 | -$7.88M | |
| 2 | -$4.31M | |
| 3 | -$2.04M | |
| 4 |
SI
Scout Investments
Kansas City,
Missouri
|
-$2M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$1.91M |